Abstract:Liying Zhan, 1, &ast Zhihua Lv, 2, &ast Yunjing Zhang, 3, &ast Jingdi Chen, 4 Lu Wang, 1 Raojuan Huang, 5 Yaqi Sun, 5 Wei Wu 1 1 Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Clinical Laboratory, Institute of Translational medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 3 Department of Ultrasound, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 4 Department of Orthopedics, the Airborne Military Hospital, Wuhan, Hubei, People's Republic of China; 5 First Clinical College of Wuhan University, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Wu, Email Purpose: Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied. Methods: We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population. Results: The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; p < 0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26). Conclusion: Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections. Keywords: metagenomic next-generation sequencing, cerebrospinal fluid, central nervous system infections, diagnosis Central nervous system (CNS) infections affecting the brain and spinal cord are primarily caused not only by bacteria and viruses but also by fungi and parasites. CNS infections are severe and life-altering conditions, and they are the most frequent cause of hospitalizations in many developing countries, making them a significant public concern. 1 Globally, CNS infectious disease has a high mortality rate. 2 It is difficult to diagnose CNS infections. Due to limited diagnostic capacity and difficulties involved in performing exploratory lumbar punctures, there is a dearth of information regarding aetiology. PCR and culture are useful techniques for detecting pathogenic bacteria, but uncommon pathogenic bacteria involving CNS infections remain difficult to identify by PCR and culture. 3 First, antibiotic treatment reduces the detection rate of CSF culture, which is the gold standard for diagnosing bacterial meningitis, and the majority of patients receive antibiotic treatment prior to lumbar puncture. Moreover, different media and cultivation conditions-some of which are intricate and time consuming-are necessary for microbial culture. The presence of Bartonella , for instance, which grows in culture for roughly two weeks, 4 reduces diagnostic efficiency. Furthermore, accurate primers are needed for PCR amplification procedures, and if the primers do not match the target nucleic acid sequence, the results may be erroneous. Thus, the rate of positive detection for PCR amplification techniques is low. 5 Overall, conventional detection techniques have several limitations, 6 and it is difficult to culture organisms from patients with CNS infections, 7 almost half of CNS infection patients cannot receive an aetiological diagnosis. 8 CNS infection diagnosis is a very challenging task. Nevertheless, precise identification of CNS infections (mixed infections) plays a vital role in clinical therapy. Recently, next-generation sequencing (NGS) has opened a window into the infectious diseases. Pathogen-targeted NGS (p -Abstract Truncated-

Next-generation Sequencing in Neuropathologic Diagnosis of Infections of the Nervous System.

Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges

Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing

Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Unexplained Central Nervous System Infections

A prospective study of nanopore-targeted sequencing in the diagnosis of central nervous system infections

Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection

Metagenomic next-generation sequencing of cerebrospinal fluid for diagnosis of central nervous system infections: 7-year performance of a clinically validated test

Clinical application and evaluation of metagenomic next-generation sequencing in pathogen detection for suspected central nervous system infections

Next-Generation Sequencing Could be a Promising Diagnostic Approach for Pathogen Detection: Pathogenic Analysis of Pediatric Bacterial Meningitis by Next-Generation Sequencing Technology Directly from Cerebrospinal Fluid Specimens

Metagenomics Next-Generation Sequencing for the Diagnosis of Central Nervous System Infection: A Systematic Review and Meta-Analysis

Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections

Diagnostic Performance Of Central Nervous System Infections In Patients With Neurosurgical Intensive Care Using Metagenomic Next-Generation Sequencing: A Prospective Observational Study

Clinical Application and Drug-Use-guidance Value of Metagenomic Next-Generation Sequencing in Central Nervous System Infection.

Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid Diagnostics

mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study

Metagenomic next-generation sequencing of cerebrospinal fluid reveals etiological and microbiological features in patients with various central nervous system infections

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections

Metagenomic Next-Generation Sequencing Contributes to the Early Diagnosis of Mixed Infections in Central Nervous System